INNOGENOMICS Technologies, LLC – Trademark Portfolio
Entity Type: 16
INNOGENOMICS Technologies, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include SPERMX, INNOQUANT, INNOTYPER, and INNOXTRACT. The owner is based in New Orleans, LA.
2000 Lakeshore Drive, Suite 5016
New Orleans, LA 70148
Showing of trademarks Trademarks
Trademark Classifications
INNOGENOMICS Technologies, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does INNOGENOMICS Technologies, LLC have?
INNOGENOMICS Technologies, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 1 cancelled.
What trademark classes does INNOGENOMICS Technologies, LLC file in?
INNOGENOMICS Technologies, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are INNOGENOMICS Technologies, LLC's most well-known trademarks?
INNOGENOMICS Technologies, LLC's registered trademark portfolio includes well-known marks such as SPERMX, INNOQUANT, INNOTYPER, and INNOXTRACT. These are among 4 currently registered trademarks in the portfolio.
What is INNOGENOMICS Technologies, LLC's trademark registration success rate?
INNOGENOMICS Technologies, LLC has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.